Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2016

Open Access 01-12-2016 | Research

Pharmacological Neuroenhancement: teachers’ knowledge and attitudes–Results from a survey study among teachers in Germany

Authors: Andreas G. Franke, Sophie Lehmberg, Michael Soyka

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2016

Login to get access

Abstract

Background

Pharmacological neuroenhancement (PN) is a topic of increasing importance. Its prevalence rates range from 1 % to more than 20 %. Students are a group that shows exceptionally high prevalence rates. However, little is known about teachers’ knowledge, management, attitudes and ethical judgements regarding PN.

Methods

A web-based survey containing 40 closed questions was developed. All teachers working at all private and public schools in Mecklenburg-Vorpommern, a state in northeastern Germany, were invited to participate after their respective school offices were contacted by telephone, email and mail.

Results

In total, 255 teachers participated in the survey. Of those, 73.3 % had already heard about PN in general, and 68.2 % had heard about PN in students. Their sources of knowledge were digital media such as TV (73.8 %) and the internet (40.6 %) and print media (64.7 %); their own students informed 29.9 % of the teachers about PN in general and 35.6 % of them about PN among students. Furthermore, 34.9 % of the surveyed teachers were convinced that PN substance use was ineffective in general, and 51.8 % of the surveyed teachers believed that PN substances were ineffective in achieving better grades. Only 1.2 % thought that none of the so-called PN substances could lead to addiction, and 37.6 % would classify PN substance use as general drug misuse. The highest values regarding risk of addiction were observed for illicit drugs. The prevalence of PN substance use was evaluated to be very low and to be significantly higher in male, highly skilled and college/university students. In total, 1.6 school lessons per year were used to discuss PN. Finally, 55.7 % of the surveyed teachers believed that performance-enhancing substances should be forbidden at schools.

Conclusion

Teachers, as an integral part of the education of children and adolescents, often know about PN substances and mostly refuse their use being afraid about the risk of addiction. However, regarding effects as well as side effects of PN substances, teachers have very different opinions. Furthermore, they seem to underestimate the prevalence among their students and broach the topic infrequently. Teachers should be sensitized for high prevalence rates and should broach the topic of PN more frequently to their students to prevent potential misuse of PN substances.
Literature
1.
2.
go back to reference Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47:21–31.CrossRefPubMed Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47:21–31.CrossRefPubMed
4.
go back to reference Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26:1501–10.CrossRefPubMedPubMedCentral Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26:1501–10.CrossRefPubMedPubMedCentral
5.
go back to reference McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;100:96–106.CrossRefPubMed McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;100:96–106.CrossRefPubMed
6.
go back to reference Webb JR, Valasek MA, North CS. Prevalence of stimulant use in a sample of US medical students. Ann Clin Psychiatry. 2013;25:27–32.PubMed Webb JR, Valasek MA, North CS. Prevalence of stimulant use in a sample of US medical students. Ann Clin Psychiatry. 2013;25:27–32.PubMed
7.
go back to reference Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, Lieb K. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44:60–6.CrossRefPubMed Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, Lieb K. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44:60–6.CrossRefPubMed
8.
go back to reference Maier LJ, Liechti ME, Herzig F, Schaub MP. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS One. 2013;8:e77967.CrossRefPubMedPubMedCentral Maier LJ, Liechti ME, Herzig F, Schaub MP. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS One. 2013;8:e77967.CrossRefPubMedPubMedCentral
9.
go back to reference Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R. Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy. 2013;33:44–50.CrossRefPubMed Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R. Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy. 2013;33:44–50.CrossRefPubMed
10.
go back to reference Liakoni E, Schaub MP, Maier LJ, Glauser GV, Liechti ME. The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students. PLoS One. 2015;10:e0141289.CrossRefPubMedPubMedCentral Liakoni E, Schaub MP, Maier LJ, Glauser GV, Liechti ME. The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students. PLoS One. 2015;10:e0141289.CrossRefPubMedPubMedCentral
11.
go back to reference Franke AG, Bagusat C, Dietz P, Hoffmann I, Simon P, Ulrich R, Lieb K. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med. 2013;11:102.CrossRefPubMedPubMedCentral Franke AG, Bagusat C, Dietz P, Hoffmann I, Simon P, Ulrich R, Lieb K. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med. 2013;11:102.CrossRefPubMedPubMedCentral
12.
go back to reference Franke AG, Bagusat C, McFarlane C, Tassone-Steiger T, Kneist W, Lieb K. The use of caffeinated substances by surgeons for cognitive enhancement. Ann Surg. 2015;26:1091–5.CrossRef Franke AG, Bagusat C, McFarlane C, Tassone-Steiger T, Kneist W, Lieb K. The use of caffeinated substances by surgeons for cognitive enhancement. Ann Surg. 2015;26:1091–5.CrossRef
14.
15.
go back to reference Maier LJ, Haug S, Schaub MP. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. Drug Alcohol Dependence. 2015;156:221–7.CrossRefPubMed Maier LJ, Haug S, Schaub MP. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. Drug Alcohol Dependence. 2015;156:221–7.CrossRefPubMed
16.
go back to reference Burgard DA, Fuller R, Becker B, Ferrell R, Dinglasan-Panlilio MJ. Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: wastewater analysis of amphetamine and ritalinic acid. Sci Total Environ. 2013;450–451:242–9.CrossRefPubMed Burgard DA, Fuller R, Becker B, Ferrell R, Dinglasan-Panlilio MJ. Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: wastewater analysis of amphetamine and ritalinic acid. Sci Total Environ. 2013;450–451:242–9.CrossRefPubMed
17.
go back to reference Franke AG, Schwarze CE, Christmann M, Bonertz C, Hildt E, Lieb K. Characteristics of university students using stimulants for cognitive enhancement: a pilot study. Psychiatr Prax. 2012;39:174–80.CrossRefPubMed Franke AG, Schwarze CE, Christmann M, Bonertz C, Hildt E, Lieb K. Characteristics of university students using stimulants for cognitive enhancement: a pilot study. Psychiatr Prax. 2012;39:174–80.CrossRefPubMed
18.
go back to reference Franke AG, Soyka M. Pharmacological cognitive enhancement from a perspective of misuse and addiction. Fortschr Neurol Psychiatr. 2015;83:83–90.CrossRefPubMed Franke AG, Soyka M. Pharmacological cognitive enhancement from a perspective of misuse and addiction. Fortschr Neurol Psychiatr. 2015;83:83–90.CrossRefPubMed
19.
go back to reference Heinz A, Kipke R, Muller S, Wiesing U. True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw. J Med Ethics. 2014;40:286–7.CrossRefPubMed Heinz A, Kipke R, Muller S, Wiesing U. True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw. J Med Ethics. 2014;40:286–7.CrossRefPubMed
20.
go back to reference Franke AG, Lieb K, Hildt E. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLoS One. 2012;7:e40047.CrossRefPubMedPubMedCentral Franke AG, Lieb K, Hildt E. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLoS One. 2012;7:e40047.CrossRefPubMedPubMedCentral
21.
go back to reference Hildt E, Lieb K, Bagusat C, Franke AG. Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study. Biomed Res Int. 2015;2015:621075.CrossRefPubMedPubMedCentral Hildt E, Lieb K, Bagusat C, Franke AG. Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study. Biomed Res Int. 2015;2015:621075.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Sattler S, Sauer C, Mehlkop G, Graeff P. The rationale for consuming cognitive enhancement drugs in university students and teachers. PLoS One. 2013;8:e68821.CrossRefPubMedPubMedCentral Sattler S, Sauer C, Mehlkop G, Graeff P. The rationale for consuming cognitive enhancement drugs in university students and teachers. PLoS One. 2013;8:e68821.CrossRefPubMedPubMedCentral
24.
go back to reference Wiegel C, Sattler S, Goritz AS, Diewald M. Work-related stress and cognitive enhancement among university teachers. Anxiety Stress Coping. 2015;1:1–18. Wiegel C, Sattler S, Goritz AS, Diewald M. Work-related stress and cognitive enhancement among university teachers. Anxiety Stress Coping. 2015;1:1–18.
25.
go back to reference Wolff W, Sandouqa Y, Brand R. Using the simple sample count to estimate the frequency of prescription drug neuroenhancement in a sample of Jordan employees. Int J Drug Policy. 2016;31:51–5.CrossRefPubMed Wolff W, Sandouqa Y, Brand R. Using the simple sample count to estimate the frequency of prescription drug neuroenhancement in a sample of Jordan employees. Int J Drug Policy. 2016;31:51–5.CrossRefPubMed
26.
go back to reference Deutsche Angestelltenkrankenkasse (DAK). DAK-Gesundheitsreport 2015. Berlin: IGES Institut GmbH; 2015. Deutsche Angestelltenkrankenkasse (DAK). DAK-Gesundheitsreport 2015. Berlin: IGES Institut GmbH; 2015.
27.
go back to reference de Jongh R, Bolt I, Schermer M, Olivier B. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev. 2008;32:760–76.CrossRefPubMed de Jongh R, Bolt I, Schermer M, Olivier B. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev. 2008;32:760–76.CrossRefPubMed
28.
go back to reference Middendorff E, Poskowsky J, Isserstedt W. Formen der Stresskompensation und Leistungssteigerung bei Studierenden. HISBUS-Befragung zur Verbreitung und zu Mustern von Hirndoping und Medikamentenmissbrauch. Hannover: HIS Hochschul-Informations-System GmbH; 2012. Middendorff E, Poskowsky J, Isserstedt W. Formen der Stresskompensation und Leistungssteigerung bei Studierenden. HISBUS-Befragung zur Verbreitung und zu Mustern von Hirndoping und Medikamentenmissbrauch. Hannover: HIS Hochschul-Informations-System GmbH; 2012.
30.
go back to reference Schelle KJ, Olthof BM, Reintjes W, Bundt C, Gusman-Vermeer J, van Mil AC. A survey of substance use for cognitive enhancement by university students in the Netherlands. Front Syst Neurosci. 2015;9:10.CrossRefPubMedPubMedCentral Schelle KJ, Olthof BM, Reintjes W, Bundt C, Gusman-Vermeer J, van Mil AC. A survey of substance use for cognitive enhancement by university students in the Netherlands. Front Syst Neurosci. 2015;9:10.CrossRefPubMedPubMedCentral
32.
go back to reference Lensvelt-Mulders G, Hox JJ, van der Heuden PG, Maas CJM. Meta-analysis of randomized response research thirty-five years of validation. Sociol Method Res. 2005;33(3):319–48.CrossRef Lensvelt-Mulders G, Hox JJ, van der Heuden PG, Maas CJM. Meta-analysis of randomized response research thirty-five years of validation. Sociol Method Res. 2005;33(3):319–48.CrossRef
33.
go back to reference Moshagen M, Musch J, Ostapczuk M, Zhao Z. Reducing socially desirable responses in epidemiologic surveys: an extension of the randomized-response technique. Epidemiology. 2010;21:379–82.CrossRefPubMed Moshagen M, Musch J, Ostapczuk M, Zhao Z. Reducing socially desirable responses in epidemiologic surveys: an extension of the randomized-response technique. Epidemiology. 2010;21:379–82.CrossRefPubMed
34.
go back to reference Ott R, Biller-Andorno N. Neuroenhancement among Swiss students--a comparison of users and non-users. Pharmacopsychiatry. 2014;47:22–8.PubMed Ott R, Biller-Andorno N. Neuroenhancement among Swiss students--a comparison of users and non-users. Pharmacopsychiatry. 2014;47:22–8.PubMed
35.
go back to reference Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M, Lieb K. Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44:331–8.CrossRefPubMed Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M, Lieb K. Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44:331–8.CrossRefPubMed
36.
go back to reference Franke AG, Bagusat C, Rust S, Engel A, Lieb K. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci. 2014;264 Suppl 1:S83–90.CrossRefPubMed Franke AG, Bagusat C, Rust S, Engel A, Lieb K. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci. 2014;264 Suppl 1:S83–90.CrossRefPubMed
37.
go back to reference Repantis D, Laisney O, Heuser I. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;61:473–81.CrossRefPubMed Repantis D, Laisney O, Heuser I. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;61:473–81.CrossRefPubMed
38.
go back to reference Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res. 2010;62:187–206.CrossRefPubMed Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res. 2010;62:187–206.CrossRefPubMed
41.
go back to reference Bisagno V, Gonzalez B, Urbano FJ. Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits. Pharmacol Res. 2016;109:108–18.CrossRefPubMed Bisagno V, Gonzalez B, Urbano FJ. Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits. Pharmacol Res. 2016;109:108–18.CrossRefPubMed
42.
go back to reference Mazanov J, Backhouse S, Connor J, Hemphill D, Quirk F. Athlete support personnel and anti-doping: Knowledge, attitudes, and ethical stance. Scand J Med Sci Sports. 2014;24:846–56.CrossRefPubMed Mazanov J, Backhouse S, Connor J, Hemphill D, Quirk F. Athlete support personnel and anti-doping: Knowledge, attitudes, and ethical stance. Scand J Med Sci Sports. 2014;24:846–56.CrossRefPubMed
43.
go back to reference Backhouse SH, McKenna J. Doping in sport: a review of medical practitioners’ knowledge, attitudes and beliefs. Int J Drug Policy. 2011;22:198–202.CrossRefPubMed Backhouse SH, McKenna J. Doping in sport: a review of medical practitioners’ knowledge, attitudes and beliefs. Int J Drug Policy. 2011;22:198–202.CrossRefPubMed
44.
go back to reference Rhodes SD, Bowie DA, Hergenrather KC. Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health. 2003;57:68–73.CrossRefPubMedPubMedCentral Rhodes SD, Bowie DA, Hergenrather KC. Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health. 2003;57:68–73.CrossRefPubMedPubMedCentral
Metadata
Title
Pharmacological Neuroenhancement: teachers’ knowledge and attitudes–Results from a survey study among teachers in Germany
Authors
Andreas G. Franke
Sophie Lehmberg
Michael Soyka
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2016
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-016-0077-y

Other articles of this Issue 1/2016

Substance Abuse Treatment, Prevention, and Policy 1/2016 Go to the issue